References
- Croxatto H B. Clinical profile of Implanon®: A single-rod etonogestrel contraceptive implant. Eur J Contracept Reprod Health Care 2000; 5(Suppl. 2)21–28
- Wiegratz I, Kuhl H. Metabolic and clinical effects of progestogens. Eur J Contracept Reprod Health Care 2006; 11: 153–161
- Washburn S A, Wagner J D, Adams M R, . Cardiovascular system: Contraceptive steroids, plasma lipoprotein levels and coronary artery atherosclerosis. Pharmacology of contraceptive steroids, J W Goldzieher, K Fotherby, et al. Raven Press, New York 1994; 335–343
- Newton J R. Classification and comparison of oral contraceptives containing new generation progestagens. Hum Reprod Update 1995; 1: 231–263
- Godsland I F, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323: 1375–1381
- Hohmann H, Creinin M D. The contraceptive implant. Clin Obstet Gynecol 2007; 50: 907–917
- Edwards J E, Moore A. Implanon: A review of clinical studies. Br J Fam Plann 1999; 24(4 Suppl.)3–16
- Mascarenhas L, van Beek A, Bennink H C, et al. Twenty-four month comparison of apolipoproteins A-1,A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom. Contraception 1998; 58: 215–219
- Suherman S K, Affandi B, Korver T. The effects of Implanon on lipid metabolism in comparison with Norplant. Contraception 1999; 60: 281–287
- Dorflinger L J. Metabolic effects of implantable steroid contraceptives for women. Contraception 2002; 65: 47–62
- Merki-Feld G S, Imthurn B, Seifert B. Effects of the progestagen-only contraceptive implant Implanon® on cardiovascular risk factors. Clin Endocrinol 2008; 68: 355–360
- Odlind V, Lithell H, Selinus I, et al. Unaltered lipoprotein and carbohydrate metabolism during treatment with contraceptive subdermal implants containing ST-1435. Ups J Med Sci 1984; 89: 151–158
- Barbosa I, Coutinho E, Athayde C, et al. The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women. Contraception 1995; 52: 111–114
- Biswas A, Viegas O A, Coelingh-Bennink H J, et al. Implanon contraceptive implants: Effects on carbohydrate metabolism. Contraception 2001; 63: 137–141
- Biswas A, Viegas O A, Bennink H J, et al. Effect of Implanon use on selected parameters of thyroid and adrenal function. Contraception 2000; 62: 247–251
- Gault M H, Chafe L, Prabkaran V. Mid-menstrual cycle decline in creatinine and urea clearances. Nephron 1994; 67: 158–166
- Paaby P, Brochner-Mortensen J, Fjelbord P, et al. Endogenous overnight creatinine clearance compared with Cr-EDTA clearance during the menstrual cycle. Acta Med Scand 1987; 222: 281–284
- Egberg N, van Beek A, Gunnervik C, et al. Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial. Contraception 1998; 58: 93–98